The goal is to establish a bio marker profile for patients whose tumors express the vitamin D receptor.
The marker profile of lung CSC remains to be explored.
Multiple-interval mapping (MIM) analyzes multiple marker intervals simultaneously to fit multiple putative QTLs.
This allows the researcher to profile multiple markers for diagnostic and prognostic purposes simultaneously, and to monitor changes over time in the markers to evaluate the efficacy of treatment.
Furthermore, in certain cases, a profile of multiple markers may shed more light on the cancer status than a single marker.
Moreover, no one marker is diagnostic of autism and the results reported here imply that panels or "signature" profiles containing multiple markers may associate more specifically with distinct symptomatology.
Efforts are now being directed toward evaluating the utility of biomarker profiles, containing multiple markers, for risk assessment and diagnosis in patients with suspected sepsis.
It is therefore logical that effort is now being directed toward evaluating the utility of biomarker profiles, containing multiple markers, for risk assessment and diagnosis in patients with suspected sepsis.
Accumulating evidence indicates that no single marker clearly identifies the ovarian CSC, and more recent reports have suggested that multiple cell populations defined by distinct marker profiles may in fact represent CSCs in EOC [ 26].
Profiling studies of multiple markers, the mechanisms of which are differentially associated with stroke pathophysiology, have tried to overcome the limitation of a single biomarker for stroke diagnosis [ 13] or outcome [ 4, 5, 10].
